SOURCE: https://www.wri.org /insights/5-ways-unlock-value-circular-economy https://www.wri.org/insights/5-ways-unlock-value-circular-economy Taking the Next Steps Take the Circular Economy to the Next Level Because sustainable material solutions and technology are evolving at the speed of life, it takes fresh thinking, agile R & D, and imaginative use of next-generation materials to bring life-changing products to market safely and quickly.

Central Office, Administration, Site management (Facitilities, EHS), Marketing and Sales, SCM, Group Procurement Services, GBS and Logistics, GTI-Engineering and R&D, Technical Application Laboratories, Legal, Finance, HR, IT, RSRA, SMD and Learning, Communication Bunkyo Green Court, 2-28-8, Tokyo Tokyo 113-8662 Japan Avient Colorants Malaysia Sdn Bhd Administration, Site management, Manufacture, Laboratory, Procurement, Maintenance, Infrastructure, Warehouse and Transport Lot 1732, MK. 15, Kaw.

Pune, India(d) 66. Winona, Minnesota Pune, India(a) (d) 8. d) Location also includes a design center/lab.

Pune, India (d) 74. Karachi, Pakistan Pune, India (a), (d) 28. d) Location also includes a design center/lab.

D O L L A R S 9 C ON SE CU TIV E Y EA RS OF AD J. Richardson 60 Executive Vice President, Chief Financial Officer Mark D. Mark D.

Stock Awards (columns (d) and (e)) Column (d) reports the vesting of RSUs during 2022 on an aggregate basis. d) “Cash Incentive Award” means a cash award granted pursuant to Section 8 of this Plan. d) Non-Employee Director Compensation Limit.

产品牌号 硬度 颜色 包覆成型 应用 密度 (g/cm3) 合规 FDA EU GB Dynalloy™ FC 3510 系列 40–80A 本色 PETG, ABS, PC 1.04 FDA 177.1210 (水性食品；条件D-G) EU 10/2010 GB 4806.6- 2016 Dynalloy™ FC 7850 & 7860 系列 30–80A 半透明/本色 PP 0.88/0.99 通用 FDA FDA 177.1210 (水性食品但酒精含量 不超过8%；条件B-G 。 对于脂肪类食品和 酒精含量超过8%的食 品；条件D-G) EU 10/2011 GB 4806.6- 2016 Versaflex™ CL2242 43A 透明 PP/PC/ABS 0.89 FDA 177.1210 (所有食品；条件A–H) FDA 177.1210 (水性食品；条件A-H) FDA 177.2600 (水性食品；条件A-H) FDA 177.2600 (水性食品；条件A-H) FDA 177.2600 (水性食品；条件A-H) FDA 177.2600 (水性食品；条件A-H) N/A N/A Versaflex™ CL2250 50A 透明 PP/PC/ABS 0.89 N/A N/A Dynaflex™ G2780C 84A 半透明 PE 0.9 N/A N/A Versaflex™ FFC 2882-50 50A 半透明 PP 0.9 EU 10/2011 N/A Versaflex™ FFC 2882-70 70A 半透明 PP 0.88 EU 10/2011 GB 4806.6- 2016 Versaflex™ FFC 2882-87 87A 半透明 PP 0.88 EU 10/2011 GB 4806.6- 2016 Versaflex™ FFC 3882-70 70A 本色 PETG, ABS, PC 1.1 EU 10/2011 Versaflex™ OM 9100 系列 30–50A 半透明 PC/ABS 0.9 FDA 177.1210 N/A N/A 食品级 TPE 适合与食品接触的热塑性弹性体 不含双酚 A(BPA)，邻苯二甲酸盐或重 金属；符合 FDA， EU10 / 2011和中国 GB4806 的等级 耐磨性及抗撕裂，经过测试，可以安全 地用于微波炉和洗碗机 具有理想的包胶性能，不仅提供柔软的 表面触感，并可根据特定的舒适度要求 进行定制，包括减少振动和降低噪音 可注塑成型或直接在PP, ABS等基材上 包覆成型 无需二次加工，保证产品质量及稳定性 产品牌号 硬度 颜色 包覆成型 密度 (g/cm3) 合规 FDA EU GB Dynalloy™ FC 3510 系列 40–80A 本色 PETG, ABS, PC 1.04 FDA 177.1210 (水性食品；条件D-G) EU 10/2010 GB 4806.6- 2016 Dynalloy™ FC 7850 & 7860 系列 30–80A 半透明/本色 PP 0.88/0.99 通用 FDA FDA 177.1210 (水性食品但酒精含量 不超过8%；条件B-G 。 对于脂肪类食品和 酒精含量超过8%的食 品；条件D-G) EU 10/2011 GB 4806.6- 2016 Versaflex™ CL2242 43A 透明 PP/PC/ABS 0.89 FDA 177.1210 (所有食品；条件A–H) FDA 177.1210 (水性食品；条件A-H) FDA 177.2600 (水性食品；条件A-H) FDA 177.2600 (水性食品；条件A-H) FDA 177.2600 (水性食品；条件A-H) FDA 177.2600 (水性食品；条件A-H) N/A N/A Versaflex™ CL2250 50A 透明 PP/PC/ABS 0.89 N/A N/A Dynaflex™ G2780C 84A 半透明 PE 0.9 N/A N/A Versaflex™ FFC 2882-50 50A 半透明 PP 0.9 EU 10/2011 N/A Versaflex™ FFC 2882-70 70A 半透明 PP 0.88 EU 10/2011 GB 4806.6- 2016 Versaflex™ FFC 2882-87 87A 半透明 PP 0.88 EU 10/2011 GB 4806.6- 2016 Versaflex™ FFC 3882-70 70A 本色 PETG, ABS, PC 1.1 EU 10/2011 Versaflex™ OM 9100 系列 30–50A 半透明 PC/ABS 0.9 FDA 177.1210 N/A N/A 食品级 TPE 适合与食品接触的热塑性弹性体 不含双酚 A(BPA)，邻苯二甲酸盐或重 金属；符合 FDA， EU10 / 2011和中国 GB4806 的等级 耐磨性及抗撕裂，经过测试，可以安全 地用于微波炉和洗碗机 具有理想的包胶性能，不仅提供柔软的 表面触感，并可根据特定的舒适度要求 进行定制，包括减少振动和降低噪音 可注塑成型或直接在PP, ABS等基材上 包覆成型 无需二次加工，保证产品质量及稳定性 产品牌号 硬度 颜色 包覆成型 版权所有© 2024埃万特公司。

Name and Principal Position (a) Year (b) Salary ($) (c) Bonus ($) (d) Stock Awards ($) (e) Option Awards ($) (f) Non-Equity Incentive Plan Compensation ($) (g) All Other Compensation ($) (h) Total ($) (i) Robert M. Rathbun — 27,438(1) 274,385(1) 548,770(1) — — — — — — 22,750(2) 182,000(2) 364,000(2) — — — — — 2/8/2021 — — — 6,717(3) 20,150(3) — 42.27 212,083 2/8/2021 — — — — — 5,050(4) — 213,464 Estimated Future Payouts Under Non-Equity Incentive Plan Awards (columns (c), (d) and (e)) (1) 2021 Annual Incentive Program Opportunities. Stock Awards (columns (d) and (e)) Column (d) reports the vesting of RSUs during 2021 on an aggregate basis.

HAFTUNGSBESCHRÄNKUNG 4.1 Unlimited Liability 4.1 Unbeschränkte Haftung The liability of Seller is not limited in the following cases: Die Haftung des Verkäufers ist in den folgenden Fällen nicht beschränkt: (A) in the event of wilful misconduct or gross negligence, (A) im Falle von Vorsatz oder grober Fahrlässigkeit, (B) within the scope of a guarantee expressly made by Seller in writing, (B) im Rahmen einer vom Verkäufer ausdrücklich und schriftlich abgegebenen Garantie, (C) in the event that a defect is maliciously concealed, (C) für den Fall, dass ein Mangel arglistig verschwiegen wurde, (D) in case of an injury to life, body or health, and (D) im Falle einer Verletzung von Leben, Körper oder Gesundheit und (E) claims under Section 1 para. 1 of the German Product Liability Act; whereby the liability of Seller for compensation claims among jointly-and-severally liable debtors pursuant to Sections 421 to 425 German Civil Code shall be excluded. HAFTUNGSBESCHRÄNKUNG 4.1 Unlimited Liability 4.1 Unbeschränkte Haftung (A) in the event of wilful misconduct or gross negligence, (A) im Falle von Vorsatz oder grober Fahrlässigkeit, (B) within the scope of a guarantee expressly made by Seller in writing, (B) im Rahmen einer vom Verkäufer ausdrücklich und schriftlich abgegebenen Garantie, (C) in the event that a defect is maliciously concealed, (C) für den Fall, dass ein Mangel arglistig verschwiegen wurde, (D) in case of an injury to life, body or health, and (D) im Falle einer Verletzung von Leben, Körper oder Gesundheit und (E) claims under Section 1 para. 1 of the German Product Liability Act; whereby the liability of Seller for compensation claims among jointly-and-severally liable debtors pursuant to Sections 421 to 425 German Civil Code shall be excluded.

DISCLAIMER Avient Corporation 3 Avient Corporation 4 Welcome Bob Patterson Chairman, President, and Chief Executive Officer INTRODUCTION Sustainability for a Better Tomorrow Jamie Beggs Senior Vice President and Chief Financial Officer Avient Corporation 5 WE ARE A FORMULATOR CUSTOM FORMULATION Avient Corporation 6 Avient Corporation 7 WE ARE INNOVATORS 2,500+ ACTIVE PATENT FILINGS WORLDWIDE 1,100+ RESEARCH AND DEVELOPMENT ASSOCIATES >85% Stage-gate technology projects enable sustainable solutions INDIA INNOVATION CENTER 33% 2022 VITALITY INDEX 140+ MATERIAL SCIENCE PhD ASSOCIATES Avient Corporation 8 3% 3% 5% Avient Specialty Formulators Other Specialty / Chemical Companies CAPEX / Revenue 2023E Global footprint enables greater flexibility to exceed needs of customers and deliver localized technical and formulation expertise 35 9 36 24 Manufacturing Locations by Region WE ARE ASSET LIGHT Note: Free cash flow conversion calculated as (Adjusted EBITDA – Capex) / Adjusted EBITDA Avient Corporation 9 Asset-light flexibility enables more nimble manufacturing capabilities and lower overhead Periods of economic weakness have driven higher levels of cash generation due to working capital improvement PROVEN TRACK RECORD OF HIGH FREE CASH FLOW CONVERSION 78% 78% 80% 80% 81% 78% 84% 83% 80% 79% 50% 55% 60% 65% 70% 75% 80% 85% 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023E 0 50 100 150 200 250 300 350 400 Fr ee C as h Fl ow C on ve rs io n Fr ee C as h Fl ow FC F $ AVNT FC F Conver si on % S&P F CF Conversion % 2 Recent Divestitures - Combined $1.7B in Proceeds PORTFOLIO EVOLUTION Avient Corporation 10 Combined $3.6B Investment in Acquisitions Since 2016 Color Business Distribution 2016 2022 PORTFOLIO TRANSFORMATION 7% 46% 66% 87% 100% 0% 20% 40% 60% 80% 100% 2005 2010 2015 2020 2023 % o f A dj us te d EB IT D A Commodity JVs Distribution Performance Products & Solutions Specialty Businesses Adjusted EBITDA from Specialty Applications Avient Corporation 11 END MARKET TRANSFORMATION Packaging Consumer Healthcare Defense Avient Corporation 12 10% 19% 8% 23% 4% 7% 7% 2006 2023E Other Industri es 78% Healthcare Consumer Packaging 22% 56% 14% 10% 43% 9% 2006 2023E Reduced Exposure to Cyclical End Markets End Market Diversification Transportation Building & Construction 57% 19% Defense IMPROVING PROFITABILITY AND EXPANDING MARGINS Avient Corporation 13 Adj.